ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
17 hedge funds and large institutions have $3.61M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 10 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
21% more capital invested
Capital invested by funds: $2.97M → $3.61M (+$633K)
35% less funds holding
Funds holding: 26 → 17 (-9)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$12.9K |
| 2 |
Renaissance Technologies
New York
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$664K |
| 2 |
PM
Platinum Management
New York
|
-$48.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 4 |
Jane Street
New York
|
-$13K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$9.99K |
ECTE Hedge Fund Activity: Q4 2014 in Review
17 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q4 2014, worth a combined $3.61M — up 21% from $2.97M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ECTE and 2 opened new positions — a net loss of 8 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $12.9K. The largest seller was Nomura Holdings, exiting entirely with an estimated $664K sold.
- 17 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q4 2014, down from 26 in Q3 2014.
- Funds reported $3.61M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q4 2014, up 21% quarter-over-quarter.
- 2 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q4 2014 and 10 closed out, a net change of -8 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q4 2014 was Goldman Sachs, an estimated $12.9K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q4 2014 was Nomura Holdings, an estimated $664K sold.
Based on aggregated 13F filings for Q4 2014.